Overview

Improvement in Bronchial Asthma in Patients With Extraesophageal Reflux After Acid Suppression

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if 20mg BID of Rabeprazole is effective in controlling GERD in patients with concomitant bronchial asthma and to assess improvement in asthma after reflux control.
Phase:
N/A
Details
Lead Sponsor:
Ponce Gastroenterology Research
Collaborator:
PriCara, Unit of Ortho-McNeil, Inc.
Treatments:
Rabeprazole